Robert Clarke, John F Peden, Jemma C Hopewell, Theodosios Kyriakou, Anuj Goel, Simon C Heath, Sarah Parish, Simona Barlera, Maria Grazia Franzosi, Stephan Rust, Derrick Bennett, Angela Silveira, Anders Malarstig, Fiona R Green, Mark Lathrop, Bruna Gigante, Karin Leander, Ulf de Faire, Udo Seedorf, Anders Hamsten, Rory Collins, Hugh Watkins, Martin Farrall. N Engl J Med 2009
Times Cited: 850
Times Cited: 850
Times Cited
Times Co-cited
Similarity
Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.
Sebhat Erqou, Stephen Kaptoge, Philip L Perry, Emanuele Di Angelantonio, Alexander Thompson, Ian R White, Santica M Marcovina, Rory Collins, Simon G Thompson, John Danesh. JAMA 2009
Sebhat Erqou, Stephen Kaptoge, Philip L Perry, Emanuele Di Angelantonio, Alexander Thompson, Ian R White, Santica M Marcovina, Rory Collins, Simon G Thompson, John Danesh. JAMA 2009
46
Genetically elevated lipoprotein(a) and increased risk of myocardial infarction.
Pia R Kamstrup, Anne Tybjaerg-Hansen, Rolf Steffensen, Børge G Nordestgaard. JAMA 2009
Pia R Kamstrup, Anne Tybjaerg-Hansen, Rolf Steffensen, Børge G Nordestgaard. JAMA 2009
41
Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.
Sotirios Tsimikas, Ewa Karwatowska-Prokopczuk, Ioanna Gouni-Berthold, Jean-Claude Tardif, Seth J Baum, Elizabeth Steinhagen-Thiessen, Michael D Shapiro, Erik S Stroes, Patrick M Moriarty, Børge G Nordestgaard,[...]. N Engl J Med 2020
Sotirios Tsimikas, Ewa Karwatowska-Prokopczuk, Ioanna Gouni-Berthold, Jean-Claude Tardif, Seth J Baum, Elizabeth Steinhagen-Thiessen, Michael D Shapiro, Erik S Stroes, Patrick M Moriarty, Børge G Nordestgaard,[...]. N Engl J Med 2020
41
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.
François Mach, Colin Baigent, Alberico L Catapano, Konstantinos C Koskinas, Manuela Casula, Lina Badimon, M John Chapman, Guy G De Backer, Victoria Delgado, Brian A Ference,[...]. Eur Heart J 2020
François Mach, Colin Baigent, Alberico L Catapano, Konstantinos C Koskinas, Manuela Casula, Lina Badimon, M John Chapman, Guy G De Backer, Victoria Delgado, Brian A Ference,[...]. Eur Heart J 2020
36
Genetic associations with valvular calcification and aortic stenosis.
George Thanassoulis, Catherine Y Campbell, David S Owens, J Gustav Smith, Albert V Smith, Gina M Peloso, Kathleen F Kerr, Sonali Pechlivanis, Matthew J Budoff, Tamara B Harris,[...]. N Engl J Med 2013
George Thanassoulis, Catherine Y Campbell, David S Owens, J Gustav Smith, Albert V Smith, Gina M Peloso, Kathleen F Kerr, Sonali Pechlivanis, Matthew J Budoff, Tamara B Harris,[...]. N Engl J Med 2013
31
Lipoprotein(a) as a cardiovascular risk factor: current status.
Børge G Nordestgaard, M John Chapman, Kausik Ray, Jan Borén, Felicita Andreotti, Gerald F Watts, Henry Ginsberg, Pierre Amarenco, Alberico Catapano, Olivier S Descamps,[...]. Eur Heart J 2010
Børge G Nordestgaard, M John Chapman, Kausik Ray, Jan Borén, Felicita Andreotti, Gerald F Watts, Henry Ginsberg, Pierre Amarenco, Alberico Catapano, Olivier S Descamps,[...]. Eur Heart J 2010
30
Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association.
Don P Wilson, Terry A Jacobson, Peter H Jones, Marlys L Koschinsky, Catherine J McNeal, Børge G Nordestgaard, Carl E Orringer. J Clin Lipidol 2019
Don P Wilson, Terry A Jacobson, Peter H Jones, Marlys L Koschinsky, Catherine J McNeal, Børge G Nordestgaard, Carl E Orringer. J Clin Lipidol 2019
30
Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis.
Stephen Burgess, Brian A Ference, James R Staley, Daniel F Freitag, Amy M Mason, Sune F Nielsen, Peter Willeit, Robin Young, Praveen Surendran, Savita Karthikeyan,[...]. JAMA Cardiol 2018
Stephen Burgess, Brian A Ference, James R Staley, Daniel F Freitag, Amy M Mason, Sune F Nielsen, Peter Willeit, Robin Young, Praveen Surendran, Savita Karthikeyan,[...]. JAMA Cardiol 2018
29
Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.
Børge G Nordestgaard, Anne Langsted. J Lipid Res 2016
Børge G Nordestgaard, Anne Langsted. J Lipid Res 2016
28
Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk.
Michelle L O'Donoghue, Sergio Fazio, Robert P Giugliano, Erik S G Stroes, Estella Kanevsky, Ioanna Gouni-Berthold, KyungAh Im, Armando Lira Pineda, Scott M Wasserman, Richard Češka,[...]. Circulation 2019
Michelle L O'Donoghue, Sergio Fazio, Robert P Giugliano, Erik S G Stroes, Estella Kanevsky, Ioanna Gouni-Berthold, KyungAh Im, Armando Lira Pineda, Scott M Wasserman, Richard Češka,[...]. Circulation 2019
28
A Test in Context: Lipoprotein(a): Diagnosis, Prognosis, Controversies, and Emerging Therapies.
Sotirios Tsimikas. J Am Coll Cardiol 2017
Sotirios Tsimikas. J Am Coll Cardiol 2017
27
Lipoprotein(a) Levels and the Risk of Myocardial Infarction Among 7 Ethnic Groups.
Guillaume Paré, Artuela Çaku, Matthew McQueen, Sonia S Anand, Enas Enas, Robert Clarke, Michael B Boffa, Marlys Koschinsky, Xingyu Wang, Salim Yusuf. Circulation 2019
Guillaume Paré, Artuela Çaku, Matthew McQueen, Sonia S Anand, Enas Enas, Robert Clarke, Michael B Boffa, Marlys Koschinsky, Xingyu Wang, Salim Yusuf. Circulation 2019
26
Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population.
Pia R Kamstrup, Anne Tybjærg-Hansen, Børge G Nordestgaard. J Am Coll Cardiol 2014
Pia R Kamstrup, Anne Tybjærg-Hansen, Børge G Nordestgaard. J Am Coll Cardiol 2014
24
Elevated Lipoprotein(a) and Risk of Ischemic Stroke.
Anne Langsted, Børge G Nordestgaard, Pia R Kamstrup. J Am Coll Cardiol 2019
Anne Langsted, Børge G Nordestgaard, Pia R Kamstrup. J Am Coll Cardiol 2019
41
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome.
Vera A Bittner, Michael Szarek, Philip E Aylward, Deepak L Bhatt, Rafael Diaz, Jay M Edelberg, Zlatko Fras, Shaun G Goodman, Sigrun Halvorsen, Corinne Hanotin,[...]. J Am Coll Cardiol 2020
Vera A Bittner, Michael Szarek, Philip E Aylward, Deepak L Bhatt, Rafael Diaz, Jay M Edelberg, Zlatko Fras, Shaun G Goodman, Sigrun Halvorsen, Corinne Hanotin,[...]. J Am Coll Cardiol 2020
23
Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials.
Nicholas J Viney, Julian C van Capelleveen, Richard S Geary, Shuting Xia, Joseph A Tami, Rosie Z Yu, Santica M Marcovina, Steven G Hughes, Mark J Graham, Rosanne M Crooke,[...]. Lancet 2016
Nicholas J Viney, Julian C van Capelleveen, Richard S Geary, Shuting Xia, Joseph A Tami, Rosie Z Yu, Santica M Marcovina, Steven G Hughes, Mark J Graham, Rosanne M Crooke,[...]. Lancet 2016
23
Statin therapy increases lipoprotein(a) levels.
Sotirios Tsimikas, Philip L S M Gordts, Chelsea Nora, Calvin Yeang, Joseph L Witztum. Eur Heart J 2020
Sotirios Tsimikas, Philip L S M Gordts, Chelsea Nora, Calvin Yeang, Joseph L Witztum. Eur Heart J 2020
22
Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER Trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin).
Amit V Khera, Brendan M Everett, Michael P Caulfield, Feras M Hantash, Jay Wohlgemuth, Paul M Ridker, Samia Mora. Circulation 2014
Amit V Khera, Brendan M Everett, Michael P Caulfield, Feras M Hantash, Jay Wohlgemuth, Paul M Ridker, Samia Mora. Circulation 2014
20
Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) Study.
Salim S Virani, Ariel Brautbar, Brian C Davis, Vijay Nambi, Ron C Hoogeveen, A Richey Sharrett, Josef Coresh, Thomas H Mosley, Joel D Morrisett, Diane J Catellier,[...]. Circulation 2012
Salim S Virani, Ariel Brautbar, Brian C Davis, Vijay Nambi, Ron C Hoogeveen, A Richey Sharrett, Josef Coresh, Thomas H Mosley, Joel D Morrisett, Diane J Catellier,[...]. Circulation 2012
20
Lipoprotein (a) measurements for clinical application.
Santica M Marcovina, John J Albers. J Lipid Res 2016
Santica M Marcovina, John J Albers. J Lipid Res 2016
20
Lipoprotein(a)-Lowering by 50 mg/dL (105 nmol/L) May Be Needed to Reduce Cardiovascular Disease 20% in Secondary Prevention: A Population-Based Study.
Christian M Madsen, Pia R Kamstrup, Anne Langsted, Anette Varbo, Børge G Nordestgaard. Arterioscler Thromb Vasc Biol 2020
Christian M Madsen, Pia R Kamstrup, Anne Langsted, Anette Varbo, Børge G Nordestgaard. Arterioscler Thromb Vasc Biol 2020
40
NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis.
Sotirios Tsimikas, Sergio Fazio, Keith C Ferdinand, Henry N Ginsberg, Marlys L Koschinsky, Santica M Marcovina, Patrick M Moriarty, Daniel J Rader, Alan T Remaley, Gissette Reyes-Soffer,[...]. J Am Coll Cardiol 2018
Sotirios Tsimikas, Sergio Fazio, Keith C Ferdinand, Henry N Ginsberg, Marlys L Koschinsky, Santica M Marcovina, Patrick M Moriarty, Daniel J Rader, Alan T Remaley, Gissette Reyes-Soffer,[...]. J Am Coll Cardiol 2018
17
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
Marc S Sabatine, Robert P Giugliano, Anthony C Keech, Narimon Honarpour, Stephen D Wiviott, Sabina A Murphy, Julia F Kuder, Huei Wang, Thomas Liu, Scott M Wasserman,[...]. N Engl J Med 2017
Marc S Sabatine, Robert P Giugliano, Anthony C Keech, Narimon Honarpour, Stephen D Wiviott, Sabina A Murphy, Julia F Kuder, Huei Wang, Thomas Liu, Scott M Wasserman,[...]. N Engl J Med 2017
17
Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study.
Sotirios Tsimikas, Nicholas J Viney, Steven G Hughes, Walter Singleton, Mark J Graham, Brenda F Baker, Jennifer L Burkey, Qingqing Yang, Santica M Marcovina, Richard S Geary,[...]. Lancet 2015
Sotirios Tsimikas, Nicholas J Viney, Steven G Hughes, Walter Singleton, Mark J Graham, Brenda F Baker, Jennifer L Burkey, Qingqing Yang, Santica M Marcovina, Richard S Geary,[...]. Lancet 2015
17
Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials.
Peter Willeit, Paul M Ridker, Paul J Nestel, John Simes, Andrew M Tonkin, Terje R Pedersen, Gregory G Schwartz, Anders G Olsson, Helen M Colhoun, Florian Kronenberg,[...]. Lancet 2018
Peter Willeit, Paul M Ridker, Paul J Nestel, John Simes, Andrew M Tonkin, Terje R Pedersen, Gregory G Schwartz, Anders G Olsson, Helen M Colhoun, Florian Kronenberg,[...]. Lancet 2018
17
Estimation of the Required Lipoprotein(a)-Lowering Therapeutic Effect Size for Reduction in Coronary Heart Disease Outcomes: A Mendelian Randomization Analysis.
Claudia Lamina, Florian Kronenberg. JAMA Cardiol 2019
Claudia Lamina, Florian Kronenberg. JAMA Cardiol 2019
23
Structure, function, and genetics of lipoprotein (a).
Konrad Schmidt, Asma Noureen, Florian Kronenberg, Gerd Utermann. J Lipid Res 2016
Konrad Schmidt, Asma Noureen, Florian Kronenberg, Gerd Utermann. J Lipid Res 2016
16
Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study.
Pia R Kamstrup, Marianne Benn, Anne Tybjaerg-Hansen, Børge G Nordestgaard. Circulation 2008
Pia R Kamstrup, Marianne Benn, Anne Tybjaerg-Hansen, Børge G Nordestgaard. Circulation 2008
15
Extreme lipoprotein(a) levels and improved cardiovascular risk prediction.
Pia R Kamstrup, Anne Tybjærg-Hansen, Børge G Nordestgaard. J Am Coll Cardiol 2013
Pia R Kamstrup, Anne Tybjærg-Hansen, Børge G Nordestgaard. J Am Coll Cardiol 2013
14
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Scott M Grundy, Neil J Stone, Alison L Bailey, Craig Beam, Kim K Birtcher, Roger S Blumenthal, Lynne T Braun, Sarah de Ferranti, Joseph Faiella-Tommasino, Daniel E Forman,[...]. Circulation 2019
Scott M Grundy, Neil J Stone, Alison L Bailey, Craig Beam, Kim K Birtcher, Roger S Blumenthal, Lynne T Braun, Sarah de Ferranti, Joseph Faiella-Tommasino, Daniel E Forman,[...]. Circulation 2019
14
Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations.
E Boerwinkle, C C Leffert, J Lin, C Lackner, G Chiesa, H H Hobbs. J Clin Invest 1992
E Boerwinkle, C C Leffert, J Lin, C Lackner, G Chiesa, H H Hobbs. J Clin Invest 1992
14
High lipoprotein(a) and high risk of mortality.
Anne Langsted, Pia R Kamstrup, Børge G Nordestgaard. Eur Heart J 2019
Anne Langsted, Pia R Kamstrup, Børge G Nordestgaard. Eur Heart J 2019
17
Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis.
Romain Capoulade, Kwan L Chan, Calvin Yeang, Patrick Mathieu, Yohan Bossé, Jean G Dumesnil, James W Tam, Koon K Teo, Ablajan Mahmut, Xiaohong Yang,[...]. J Am Coll Cardiol 2015
Romain Capoulade, Kwan L Chan, Calvin Yeang, Patrick Mathieu, Yohan Bossé, Jean G Dumesnil, James W Tam, Koon K Teo, Ablajan Mahmut, Xiaohong Yang,[...]. J Am Coll Cardiol 2015
14
Oxidized phospholipids as a unifying theory for lipoprotein(a) and cardiovascular disease.
Michael B Boffa, Marlys L Koschinsky. Nat Rev Cardiol 2019
Michael B Boffa, Marlys L Koschinsky. Nat Rev Cardiol 2019
17
Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies.
J Danesh, R Collins, R Peto. Circulation 2000
J Danesh, R Collins, R Peto. Circulation 2000
13
Race is a key variable in assigning lipoprotein(a) cutoff values for coronary heart disease risk assessment: the Multi-Ethnic Study of Atherosclerosis.
Weihua Guan, Jing Cao, Brian T Steffen, Wendy S Post, James H Stein, Mathew C Tattersall, Joel D Kaufman, Joseph P McConnell, Daniel M Hoefner, Russell Warnick,[...]. Arterioscler Thromb Vasc Biol 2015
Weihua Guan, Jing Cao, Brian T Steffen, Wendy S Post, James H Stein, Mathew C Tattersall, Joel D Kaufman, Joseph P McConnell, Daniel M Hoefner, Russell Warnick,[...]. Arterioscler Thromb Vasc Biol 2015
15
Phenotypic Characterization of Genetically Lowered Human Lipoprotein(a) Levels.
Connor A Emdin, Amit V Khera, Pradeep Natarajan, Derek Klarin, Hong-Hee Won, Gina M Peloso, Nathan O Stitziel, Akihiro Nomura, Seyedeh M Zekavat, Alexander G Bick,[...]. J Am Coll Cardiol 2016
Connor A Emdin, Amit V Khera, Pradeep Natarajan, Derek Klarin, Hong-Hee Won, Gina M Peloso, Nathan O Stitziel, Akihiro Nomura, Seyedeh M Zekavat, Alexander G Bick,[...]. J Am Coll Cardiol 2016
13
Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes.
Daniel F Gudbjartsson, Gudmundur Thorgeirsson, Patrick Sulem, Anna Helgadottir, Arnaldur Gylfason, Jona Saemundsdottir, Eythor Bjornsson, Gudmundur L Norddahl, Aslaug Jonasdottir, Adalbjorg Jonasdottir,[...]. J Am Coll Cardiol 2019
Daniel F Gudbjartsson, Gudmundur Thorgeirsson, Patrick Sulem, Anna Helgadottir, Arnaldur Gylfason, Jona Saemundsdottir, Eythor Bjornsson, Gudmundur L Norddahl, Aslaug Jonasdottir, Adalbjorg Jonasdottir,[...]. J Am Coll Cardiol 2019
25
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol.
Kausik K Ray, R Scott Wright, David Kallend, Wolfgang Koenig, Lawrence A Leiter, Frederick J Raal, Jenna A Bisch, Tara Richardson, Mark Jaros, Peter L J Wijngaard,[...]. N Engl J Med 2020
Kausik K Ray, R Scott Wright, David Kallend, Wolfgang Koenig, Lawrence A Leiter, Frederick J Raal, Jenna A Bisch, Tara Richardson, Mark Jaros, Peter L J Wijngaard,[...]. N Engl J Med 2020
13
LPA Gene, Ethnicity, and Cardiovascular Events.
Sang-Rok Lee, Anand Prasad, Yun-Seok Choi, Chao Xing, Paul Clopton, Joseph L Witztum, Sotirios Tsimikas. Circulation 2017
Sang-Rok Lee, Anand Prasad, Yun-Seok Choi, Chao Xing, Paul Clopton, Joseph L Witztum, Sotirios Tsimikas. Circulation 2017
23
Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes).
John J Albers, April Slee, Kevin D O'Brien, Jennifer G Robinson, Moti L Kashyap, Peter O Kwiterovich, Ping Xu, Santica M Marcovina. J Am Coll Cardiol 2013
John J Albers, April Slee, Kevin D O'Brien, Jennifer G Robinson, Moti L Kashyap, Peter O Kwiterovich, Ping Xu, Santica M Marcovina. J Am Coll Cardiol 2013
13
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.
Gregory G Schwartz, P Gabriel Steg, Michael Szarek, Deepak L Bhatt, Vera A Bittner, Rafael Diaz, Jay M Edelberg, Shaun G Goodman, Corinne Hanotin, Robert A Harrington,[...]. N Engl J Med 2018
Gregory G Schwartz, P Gabriel Steg, Michael Szarek, Deepak L Bhatt, Vera A Bittner, Rafael Diaz, Jay M Edelberg, Shaun G Goodman, Corinne Hanotin, Robert A Harrington,[...]. N Engl J Med 2018
12
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.
C Baigent, L Blackwell, J Emberson, L E Holland, C Reith, N Bhala, R Peto, E H Barnes, A Keech, J Simes,[...]. Lancet 2010
C Baigent, L Blackwell, J Emberson, L E Holland, C Reith, N Bhala, R Peto, E H Barnes, A Keech, J Simes,[...]. Lancet 2010
12
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
Christopher P Cannon, Michael A Blazing, Robert P Giugliano, Amy McCagg, Jennifer A White, Pierre Theroux, Harald Darius, Basil S Lewis, Ton Oude Ophuis, J Wouter Jukema,[...]. N Engl J Med 2015
Christopher P Cannon, Michael A Blazing, Robert P Giugliano, Amy McCagg, Jennifer A White, Pierre Theroux, Harald Darius, Basil S Lewis, Ton Oude Ophuis, J Wouter Jukema,[...]. N Engl J Med 2015
12
Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease: Prospective 5 Years of Follow-Up and Apolipoprotein(a) Characterization.
Eberhard Roeseler, Ulrich Julius, Franz Heigl, Ralf Spitthoever, Dennis Heutling, Paul Breitenberger, Josef Leebmann, Walter Lehmacher, Pia R Kamstrup, Børge G Nordestgaard,[...]. Arterioscler Thromb Vasc Biol 2016
Eberhard Roeseler, Ulrich Julius, Franz Heigl, Ralf Spitthoever, Dennis Heutling, Paul Breitenberger, Josef Leebmann, Walter Lehmacher, Pia R Kamstrup, Børge G Nordestgaard,[...]. Arterioscler Thromb Vasc Biol 2016
12
Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial.
Michael Szarek, Vera A Bittner, Philip Aylward, Marie Baccara-Dinet, Deepak L Bhatt, Rafael Diaz, Zlatko Fras, Shaun G Goodman, Sigrun Halvorsen, Robert A Harrington,[...]. Eur Heart J 2020
Michael Szarek, Vera A Bittner, Philip Aylward, Marie Baccara-Dinet, Deepak L Bhatt, Rafael Diaz, Zlatko Fras, Shaun G Goodman, Sigrun Halvorsen, Robert A Harrington,[...]. Eur Heart J 2020
29
A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms.
Salome Mack, Stefan Coassin, Rico Rueedi, Noha A Yousri, Ilkka Seppälä, Christian Gieger, Sebastian Schönherr, Lukas Forer, Gertraud Erhart, Pedro Marques-Vidal,[...]. J Lipid Res 2017
Salome Mack, Stefan Coassin, Rico Rueedi, Noha A Yousri, Ilkka Seppälä, Christian Gieger, Sebastian Schönherr, Lukas Forer, Gertraud Erhart, Pedro Marques-Vidal,[...]. J Lipid Res 2017
16
Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis.
Kang H Zheng, Sotirios Tsimikas, Tania Pawade, Jeffrey Kroon, William S A Jenkins, Mhairi K Doris, Audrey C White, Nyanza K L M Timmers, Jesper Hjortnaes, Maximillian A Rogers,[...]. J Am Coll Cardiol 2019
Kang H Zheng, Sotirios Tsimikas, Tania Pawade, Jeffrey Kroon, William S A Jenkins, Mhairi K Doris, Audrey C White, Nyanza K L M Timmers, Jesper Hjortnaes, Maximillian A Rogers,[...]. J Am Coll Cardiol 2019
12
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.